Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
Antimalarial drugs have usually been first deployed in areas of malaria endemicity at doses which were too low, particularly for high-risk groups such as young children and pregnant women. This may accelerate the emergence and spread of resistance, thereby shortening the useful life of the drug, but...
প্রধান লেখক: | White, N |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
2013
|
অনুরূপ উপাদানগুলি
-
Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
অনুযায়ী: Banda, CG, অন্যান্য
প্রকাশিত: (2024) -
Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
অনুযায়ী: Kloprogge, F
প্রকাশিত: (2013) -
Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
অনুযায়ী: Tarning, J, অন্যান্য
প্রকাশিত: (2014) -
Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
অনুযায়ী: Tarning, J, অন্যান্য
প্রকাশিত: (2014) -
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
অনুযায়ী: White, N
প্রকাশিত: (1997)